Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 15

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 15
---
, is an entrepreneurial leader with over 25 years of experience in the healthcare field. He is the Founder of Blue Water Venture Partners, LLC, an investment firm, where he is also the Senior Managing Partner. Along with Blue Water Venture Partners, LLC, Mr. Hernandez is the Chairman and Founder of several other biotechnology companies including, Perseus Therapeutics, Inc., spun out of Duke University and focused on developing novel therapies for preventing hair loss in chemotherapy-treated cancer patients and for cosmetic use; Temple Street Biotech, Inc., focused on advancing Alzheimer’s disease treatments; Eternity Biotech, spun out of Yale University and committed to developing advancements life extension; and Energia Power Systems, Inc., spun out of Stanford University, a novel battery company. Mr. Hernandez has a background in company creation, early stage technology development, as well as private and public market financing. Mr. Hernandez brings leadership to the team, backed by a strong educational foundation in biology, medicine, molecular genetics, microbiology, epidemiology, marketing, and finance. Over the course of his career, he has founded or led fourteen entrepreneurial companies in cutting edge areas of healthcare and pharmaceuticals. After years of building his career at Merck & Co. (NYSE: MRK) from December 1998 to January 2001, and Digene Corp., a medical diagnostics firm (acquired by Qiagen NV (NYSE: QGEN)) from 2005 to 2009, Mr. Hernandez founded and became the President and Chief Executive Officer of Innovative Biosensors, Inc., a biotech company, from 2004 to 2009. Later, Mr. Hernandez served as the Founder and Chairman of Microlin Bio Inc., a biopharmaceutical company, from August 2013 to January 2017, and as Chairman of the Board of Ember Therapeutics, Inc. (OTCMKTS: EMBT) from April 2014 to January 2019. He was also the Chairman of Sydys Corporation from May 2016 to January 2019. In 2018, Mr. Hernandez founded Blue Water Vaccines Inc., an early stage biotechnology company focused on manufacturing a universal influenza vaccine in partnership with the University of Oxford in England. In January 2020 he founded, and in May 2020 sold, Noachis Terra, Inc. (acquired by Qiagen NV (NYSE: OGEN)) a company developing a vaccine for COVID-19. From May 2020 to September